Yield10 Bioscience, Inc. (YTEN)

Market Cap	552.61K
Revenue (ttm)	750.00K
Net Income (ttm)	-12.70M
Shares Out	665.79K
EPS (ttm)	-24.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,400
Open	1.050
Previous Close	0.950
Day's Range	0.830 - 1.050
52-Week Range	0.530 - 17.280
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscienc...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1992
• Employees: 29
• Stock Exchange: OTCMKTS
• Ticker Symbol: YTEN

Financial Performance

In 2023, Yield10 Bioscience's revenue was $60,000, a decrease of -86.67% compared to the previous year's $450,000. Losses were -$14.46 million, 6.55% more than in 2022.